← Back to Search

Uric Acid and Metabolite Monitor System (UR+AIMS) skin patch for Gout

N/A

Waitlist Available

Led By John FitzGerald, MD

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age > 18 with diagnosis of gout (screening positive ACR/EULAR Gout Classification Criteria - see screening survey) and eGFR > 60 (within the last 12-months)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 years

Awards & highlights

Study Summary

This trial will invite 15 patients with gout to participate in a meal at UCLA and a 7-day follow-up. They will use a skin patch to measure uric acid levels and other substances

Who is the study for?

This trial is for 15 people with gout, some of whom haven't had recent urate-lowering therapy and others who are on a stable urate-lowering regimen. Participants will join a meal study at UCLA and then wear a skin patch that monitors uric acid levels for a week.Check my eligibility

What is being tested?

The UR+AIMS skin patch, which tracks uric acid and other metabolites in patients with gout, is being tested. The study involves eating a standardized meal followed by wearing the patch to monitor changes over seven days.See study design

What are the potential side effects?

Potential side effects aren't specified but may include skin irritation or allergic reactions where the patch is applied. As this device monitors levels without administering drugs, systemic side effects are unlikely.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18, have gout, and my kidney function is good.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Evaluate tolerability and adherence of daily recorded patch wear time.

Recording of uric acid (and oxypurinol) measurements while wearing patch.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Uric Acid and Metabolite Monitor System (UR+AIMS) skin patchExperimental Treatment1 Intervention

15 patients with gout will be invited to participate in a standardized meal at the UCLA Human Nutrition Center and a 7-day community follow up for the measurement of uric acid (and other metabolites) using our Uric Acid and Metabolite Monitor System (UR+AIMS) skin patch.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor

1,532 Previous Clinical Trials

10,265,253 Total Patients Enrolled

1 Trials studying Gout

9 Patients Enrolled for Gout

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,359 Previous Clinical Trials

4,314,577 Total Patients Enrolled

1 Trials studying Gout

30 Patients Enrolled for Gout

John FitzGerald, MDPrincipal InvestigatorUniversity of California, Los Angeles

1 Previous Clinical Trials

9 Total Patients Enrolled

1 Trials studying Gout

9 Patients Enrolled for Gout

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for this study currently available to prospective participants?

"As per the information provided on clinicaltrials.gov, this particular study is currently not accepting new participants. The trial was initially posted on January 31st, 2024 and last updated on December 15th, 2023. However, it is worth noting that there are presently 31 other trials actively seeking candidates for participation."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

UR+AIMS Gout Wearable Skin Uric Acid Monitor Study

John D. Fitzgerald, MD, PhD 2024. "UR+AIMS Gout Wearable Skin Uric Acid Monitor Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06187519.

All > Gout